See also this year's filing and all EDGAR filings for this company.
PDF Report 0001439222_2022_AGIOS_PHARMACEUTICALS_INC.pdf
Logs
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001439222')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001439222, AGIOS PHARMACEUTICALS INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,064,231,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 28,923,000 |
| 3 | remainder_Assets | 344,582,000 |
| 4 | LiabilitiesCurrent | 59,826,000 |
| 5 | LiabilitiesNoncurrent | 85,659,000 |
| 6 | remainder_Liabilities | 276,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 121,445,000 |
| 9 | ResearchAndDevelopmentExpense | 256,973,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,983,133,000 |
| 13 | remainder_ComprehensiveNetIncome | -1,303,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,437,736,000 |
| 1 | Liabilities | 145,761,000 |
| 2 | Expenses | 378,418,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 1,291,975,000 |
| 5 | NetIncome | 1,604,715,000 |
| 6 | ComprehensiveNetIncome | 1,604,063,500 |
| 7 | BaseVar | 1,973,175,500 |
| 8 | EconomicCapitalRatio | 4.83 |
Edgar->Model Mapping
Feature Distribution
Change over Time
